Scientists have long known that women’s preferences for masculine men change throughout their menstrual cycles. A new study from Indiana University’s Kinsey Institute is the first to demonstrate differences in brain activity as women considered masculinized and feminized male faces and whether the person was a potential sexual partner. The researchers identified regions of the
Full Post: Researchers identify regions of female brain that respond more strongly to masculine faces
Scientists funded by the Biotechnology and Biological Sciences Research Council (BBSRC) have identified a potential new avenue for altering lung development in the embryo which may help to improve the outcome for very premature babies.
The researchers at Cardiff University, in collaboration with those at the Saban Research Institute at Los Angeles Children’s Hospital, have discovered a key player in early lung development which is a potential drug target for treating very premature babies with small, immature lungs. The research is published today (12th December 2008) in The Journal of Physiology . The work was carried out in the laboratories of Dr Daniela Riccardi and Professor Paul Kemp (School of Biosciences, Cardiff University, UK) in collaboration with Professor David Warburton (Saban Research Institute, Childrens Hospital Los Angeles, USA).
Dr. Riccardi said: “Within minutes of birth, a baby relies solely on its lungs to get the oxygen it needs. One of the reasons that the lives of very premature babies are in such dire jeopardy is that the final stages of lung development happen very late in pregnancy and so premature babies are born with immature lungs that struggle to take in enough oxygen. Under-developed lungs don’t absorb enough oxygen and premature babies with respiratory problems often develop chronic lung disease that may extend into adulthood. Through our research we have gained a better understanding of how lungs develop normally and so we can now begin to work out what happens when things go wrong, such as when a baby is born much too early. From the work we have published today, we now have a real possibility for fast-tracking new drugs for helping these very premature babies.”
Along with their research associates Dr Brenda Finney and Dr William Wilkinson, Dr Riccardi and Professor Kemp have discovered that a molecule called CaR (calcium receptor) is a crucial factor in the control of lung development in the womb. CaR co-ordinates messages from within the growing fetus that instruct the lungs to develop thousands of channels and tiny air pockets. This complicated structure is what will ultimately allow oxygen to move from the air into the baby’s blood stream.
Professor Kemp said: “The really exciting thing about CaR is that there are already drugs available that can alter its function and, therefore, could modulate lung development. We know that CaR works by sensing calcium and we also know that there are already drugs available that are designed to regulate how calcium is used in the body. If we can show that one of these drugs can modulate the action of CaR in the lung, it could be used to mature the lungs of a very premature baby as it grows. Better still, an existing drug could potentially be approved much more quickly than a new one.”
Professor Janet Allen, BBSRC Director of Research said: “It is exciting to see that BBSRC-funded research has the potential to improve the lives of thousands of very premature babies. These scientists have shown that by first asking questions about a fundamental biological process, the possibilities for understanding and treating devastating human disease can then be thrown wide open. This demonstrates the value of basic research in biology for delivering real life impact.”
http://www.bbsrc.ac.uk/
--------------------------------------------------------------------------------------------
Related Posts:
Scientists have identified a gene critical to lung maturation in newborns and the production of surfactant, which lines lung tissues and prevents the lungs from collapsing. In a study posted online by the Proceedings of the National Academy of Sciences (PNAS), investigators at Cincinnati Children’s Hospital Medical Center deleted the Foxm1 gene in embryonic mice.
Full Post: Foxm1 gene mutation may cause immature lungs in newborns
Adelaide researchers have made a world breakthrough in treating premature babies at risk of developmental disorders. A six-year study led by Dr Maria Makrides from the Women’s and Children’s Health Research Institute and Professor Bob Gibson from the University of Adelaide has demonstrated that high doses of fatty acids administered to pre-term infants via their
Full Post: Breakthrough in treating premature babies at risk of developmental disorders
A class of drugs that are used in premature infants to treat chronic lung damage can cause damage in the brain. New research at Washington University School of Medicine in St. Louis suggests the drugs may cause cognitive and motor-control problems even when they are given before birth. The researchers have identified the cells damaged
Full Post: Glucocorticoids may cause damage in the brain
Women can usually keep using the same asthma drugs they were using before they got pregnant. Budesonide sprays are the best studied and can be regarded as safe. More trials of other essential medicines are necessary however. According to the German Institute for Quality and Efficiency in Health Care (IQWiG), more data from trials could
Full Post: Pregnant women with asthma can be more confident about some medicines
According to a study by Australian researchers premature babies who were given high doses of omega-3 fatty acid were less likely to have developmental delays - but this only applied to baby girls. Premature babies are often born before their brains have fully developed and some are thought to have inadequate DHA while their
Full Post: Fish oil helps premmie baby girls avoid learning disabilities --------------------------------------------------------------------------------------------
